CorMedix (CRMD) Total Liabilities (2010 - 2025)

CorMedix has disclosed Total Liabilities across 16 years of filings, most recently posting $420.8 million for Q4 2025.

• Total Liabilities for Q4 2025 came in at $420.8 million, up 1130.91% year-over-year; the trailing twelve-month figure through Dec 2025 was $420.8 million (up 1130.91% YoY), and the FY2025 annual result was $420.8 million, up 1130.91% from the prior year.
• Total Liabilities came in at $420.8 million for Q4 2025 at CorMedix, up from $376.7 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $420.8 million in Q4 2025 to a low of $3.9 million in Q1 2021.
• The 5-year median for Total Liabilities is $8.1 million (2023), against an average of $50.8 million.
• Across the five-year window, Total Liabilities plunged 32.08% in 2021 and jumped 1896.05% in 2025, its largest moves.
• CorMedix's Total Liabilities stood at $6.1 million in 2021, then climbed by 13.52% to $7.0 million in 2022, then jumped by 70.77% to $11.9 million in 2023, then jumped by 186.88% to $34.2 million in 2024, then soared by 1130.91% to $420.8 million in 2025.
• The last three Total Liabilities figures came in at $420.8 million (Q4 2025), $376.7 million (Q3 2025), and $32.0 million (Q2 2025), per Business Quant data.